Ask AI
KOMET 007
KOMET-007: Phase Ib Study of Ziftomenib + Venetoclax/Azacitidine in Newly Diagnosed NPM1-Mutated Acute Myeloid Leukemia

Released: December 16, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 16, 2025